Diabetic Patients: Some Benefits from Fibrates

Diabetic Patients: Some Benefits from Fibrates

0:00
17 November 2005

Anthony Keech Among nearly 10 000 patients with maturity onset diabetes the use of fenofibrate to lower cholesterol produced a 24 per cent statistically significant reduction of cardiovascular events,

Anthony Keech

Anthony Keech

Among nearly 10 000 patients with maturity onset diabetes the use of fenofibrate to lower cholesterol produced a 24 per cent statistically significant reduction of cardiovascular events, but no reduction in the risk of death.Anthony Keechof University of Sydney told AHA delegates about his findings.

Click here for all the interviews from AHA 2005